Geron (NASDAQ:GERN) Receives New Coverage from Analysts at Scotiabank

Scotiabank assumed coverage on shares of Geron (NASDAQ:GERN – Free Report) in a research report report published on Wednesday, Marketbeat reports. The firm issued a sector outperform rating and a $6.00 price target on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the company. Wedbush reissued an “outperform” rating […]

Leave a Reply

Your email address will not be published.

Previous post Cheetah Mobile (NYSE:CMCM) Now Covered by Analysts at StockNews.com
Next post MLB notes: Red Sox boss Craig Breslow lays out ‘future is now’ vision for pivotal offseason